The anti-tumor efficacy of antibiotics primarily depends on the reduction of IL-17A, this depletion results in an increase in anti-tumor T cells secreting IFN-γ within the tumor microenvironment and a decrease in pro-tumor T cells producing IL-17A and IL-10 (Sethi et al., 2018). The gene discussed is IL17A; the disease is neoplasm.